NCAM1 and renal cell carcinoma: The expression of the lysosomal marker CD107a, which correlates with NK cell cytotoxicity [42] was evaluated by immunofluorescence and flow cytometry analysis by gating on CD56+ human peripheral blood NK cells contacting treated or untreated RCC cells used as target.